Sensei Biotherapeutics (SNSE) Earnings Date & Reports
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
SNSE is expected to report earnings to fall 11.11% to -23 cents per share on July 31
Q2'25
Est.
$-0.24
Q1'25
Missed
by $0.04
Q4'24
Missed
by $0.03
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.01
The last earnings report on May 06 showed earnings per share of -27 cents, missing the estimate of -23 cents. With 2.45K shares outstanding, the current market capitalization sits at 10.83M.